Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Mipasetamab uzoptirine (ADCT-601) is an antibody-drug conjugate (ADC) targeting AXL. It combines a humanized anti-AXL antibody with a cleavable linker and the potent pyrrolobenzodiazepine (PBD) dimer cytotoxin SG3199. Mipasetamab uzoptirine is utilized in cancer research [1].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | Inquiry | Inquiry | |
50 mg | Inquiry | Inquiry |
Description | Mipasetamab uzoptirine (ADCT-601) is an antibody-drug conjugate (ADC) targeting AXL. It combines a humanized anti-AXL antibody with a cleavable linker and the potent pyrrolobenzodiazepine (PBD) dimer cytotoxin SG3199. Mipasetamab uzoptirine is utilized in cancer research [1]. |
Molecular Weight | N/A |
CAS No. | 2304799-73-1 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Mipasetamab uzoptirine 2304799-73-1 inhibitor inhibit